Where does Asia Pacific Medical Technology Development Company, Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Asia Pacific Medical Technology Development Company, Ltd ranks #34,335 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Asia Pacific Medical Technology Development Company, Ltd's patent grant rate increasing or decreasing?

Asia Pacific Medical Technology Development Company, Ltd's recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Asia Pacific Medical Technology Development Company, Ltd's patents?

Asia Pacific Medical Technology Development Company, Ltd's patents average 18.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Asia Pacific Medical Technology Development Company, Ltd

Q: How many patents does Asia Pacific Medical Technology Development Company, Ltd hold?

Asia Pacific Medical Technology Development Company, Ltd holds 7 US utility patents granted between 2017 and 2022, spanning 3 technology areas.

Q: What is Asia Pacific Medical Technology Development Company, Ltd's Innovation Score?

Asia Pacific Medical Technology Development Company, Ltd has an Innovation Score of 25.6 out of 100 (18th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Q: What technology areas does Asia Pacific Medical Technology Development Company, Ltd focus on?

Asia Pacific Medical Technology Development Company, Ltd's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 6 patents. Grants appear in 3 CPC subclasses total.

Q: How is the Asia Pacific Medical Technology Development Company, Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Asia ranks #34,335 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.

#34,335
of 49,997 US assignees by volume: 18th percentile
by Innovation Score (25.6/100): 18.3
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34335 · Foreign Corporation #34,335 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,335/49,997
PHOTO-FINISH Artax Biopharma
CPC-NARROW A61M · 3 areas
INNOV-THIN 25.6/100
CLAIMS-RICH 18.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Artax Biopharma Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
A P Racing · near

26
Asia Pacific… · this assignee

26
A Celli Paper S P A · near

26
HTR Development · near

26
Tarng Yu Enterprise · near

26
3D Lighting… · lowest

7

What this shows Asia's Innovation Score is 25.6/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Asia's grants concentrate

Asia Pacific Medical Technology Development Company, Ltd is a focused PatentsView assignee: 3 CPC subclasses with 85.7% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2017. By volume, Asia sits between Artax Biopharma Inc. and Athenex HK Innovative Limited.

Asia's three-year grant acceleration

Asia Pacific Medical Technology Development Company, Ltd shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Artax Biopharma

7
Artificial

7
Asco Numatics

7
Asha Medical

7
Asset Integrity M…

7
Asteriondb

7
Athena Diagnostics

7
Athenex HK Innova…

7
Asia Pacific Medi… ◀

7

What this shows Asia holds 7 patents at rank #34,361, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Asia

By rank, the assignees closest to #34,361 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Asia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Asia, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (26 here).

A.P. Racing Ltd. 26 A. Celli Paper S.P.A. 26 HTR Development LLC 26 Tarng Yu Enterprise co., ltd. 26

Asia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Asia Pacific Medical Technology Development Company, Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	14.3%
2019	2	28.6%
2020	1	14.3%
2021	2	28.6%
2022	1	14.3%

Which technologies does Asia Pacific Medical Technology Development Company, Ltd patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#34,335

of 49,997 tracked assignees

Innovation Score

25.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Asia Pacific Medical Technology Development Company, Ltd's patent record in context - here's where to go next.

Asia Pacific Medical Technology Development Company, Ltd's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 85.7% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #34,335 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Asia Pacific Medical Technology Development Company, Ltd against Artax Biopharma Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.